FDA Drug Application (202385) for FELBAMATE by AMNEAL PHARMS

Back to FDA Applications sponsored by AMNEAL PHARMS

Application Number202385
Product Number001
FormSUSPENSION;ORAL
Dosage600MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameFELBAMATE
Active IngredientFELBAMATE



Back to FDA Applications sponsored by AMNEAL PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.